Characterising infectious disease mortality in severe mental illness: A retrospective matched cohort study

preprint OA: gold CC-BY-4.0
📄 Open PDF Full text JSON View at publisher
Full text 1,897 characters · extracted from oa-doi-fallback · 2 sections · click to expand

Background

Evidence suggests that people with severe mental illness (SMI) are at an increased risk of infection mortality compared to the general population. Little is known about how this risk might differ across infection types, and the potential impact of sociodemographic and clinical factors. We investigated associations between SMI and infection mortality in a population-based cohort, examining variation by infection type and potential moderating factors. Study design This retrospective matched cohort study used national primary care data from the Clinical Practice Research Datalink (CPRD) from 1 January 2000 to 31 December 2019 linked with Office of National Statistics (ONS) mortality data. Competing risks regression and cause-specific hazard models assessed risk of infection mortality in people with SMI versus non-SMI controls. We examined risk across different infection types and assessed the impact of sociodemographic and clinical factors. Study results Our cohort comprised 84,494 people with SMI matched on age, gender, and GP practice with 84,494 non-SMI controls. Fully adjusted models showed that people with SMI were more likely to die from any infection compared to non-SMI controls (adjusted hazards ratio (aHR)=1.58, 95% confidence intervals (CI)=1.44 to 1.74). Infection-specific analyses revealed increased risk of death from respiratory (aHR=1.69, 95% CI=1.51 to 1.89), gastrointestinal (aHR=2.01, 95% CI=1.16 to 3.48), and renal/urinary (aHR=1.70, 95% CI=1.32 to 2.19) infections in the SMI group.

Conclusions

People with SMI are at increased risk of infection mortality, especially from respiratory, gastrointestinal, and renal/urinary infections. We recommend prioritising this group for preventative measures including influenza and pneumococcal vaccines. Footnotes Funding: This work was supported by MQ Mental Health Research Fellowship (MGF22\12).

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

Ask this paper AI returns verbatim quotes from the full text · source: oa-doi-fallback

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2025) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.

Source provenance

europepmc
last seen: 2026-05-20T01:45:00.602351+00:00
unpaywall
last seen: 2026-05-21T05:10:58.409756+00:00
License: CC-BY-4.0